A Stroke Care Model at an Academic, Comprehensive Stroke Center During the 2020 COVID-19 Pandemic.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 03 04 2020
revised: 08 04 2020
accepted: 29 04 2020
pubmed: 22 5 2020
medline: 30 7 2020
entrez: 22 5 2020
Statut: ppublish

Résumé

The COVID-19 pandemic has required the adaptation of hyperacute stroke care (including stroke code pathways) and hospital stroke management. There remains a need to provide rapid and comprehensive assessment to acute stroke patients while reducing the risk of COVID-19 exposure, protecting healthcare providers, and preserving personal protective equipment (PPE) supplies. While the COVID infection is typically not a primary cerebrovascular condition, the downstream effects of this pandemic force adjustments to stroke care pathways to maintain optimal stroke patient outcomes. The University of California San Diego (UCSD) Health System encompasses two academic, Comprehensive Stroke Centers (CSCs). The UCSD Stroke Center reviewed the national COVID-19 crisis and implications on stroke care. All current resources for stroke care were identified and adapted to include COVID-19 screening. The adjusted model focused on comprehensive and rapid acute stroke treatment, reduction of exposure to the healthcare team, and preservation of PPE. The adjusted pathways implement telestroke assessments as a specific option for all inpatient and outpatient encounters and accounts for when telemedicine systems are not available or functional. COVID screening is done on all stroke patients. We outline a model of hyperacute stroke evaluation in an adapted stroke code protocol and novel methods of stroke patient management. The overall goal of the model is to preserve patient access and outcomes while decreasing potential COVID-19 exposure to patients and healthcare providers. This model also serves to reduce the use of vital PPE. It is critical that stroke providers share best practices via academic and vetted social media platforms for rapid dissemination of tools and care models during the COVID-19 crisis.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
The COVID-19 pandemic has required the adaptation of hyperacute stroke care (including stroke code pathways) and hospital stroke management. There remains a need to provide rapid and comprehensive assessment to acute stroke patients while reducing the risk of COVID-19 exposure, protecting healthcare providers, and preserving personal protective equipment (PPE) supplies. While the COVID infection is typically not a primary cerebrovascular condition, the downstream effects of this pandemic force adjustments to stroke care pathways to maintain optimal stroke patient outcomes.
METHODS METHODS
The University of California San Diego (UCSD) Health System encompasses two academic, Comprehensive Stroke Centers (CSCs). The UCSD Stroke Center reviewed the national COVID-19 crisis and implications on stroke care. All current resources for stroke care were identified and adapted to include COVID-19 screening. The adjusted model focused on comprehensive and rapid acute stroke treatment, reduction of exposure to the healthcare team, and preservation of PPE.
AIMS OBJECTIVE
The adjusted pathways implement telestroke assessments as a specific option for all inpatient and outpatient encounters and accounts for when telemedicine systems are not available or functional. COVID screening is done on all stroke patients. We outline a model of hyperacute stroke evaluation in an adapted stroke code protocol and novel methods of stroke patient management.
CONCLUSIONS CONCLUSIONS
The overall goal of the model is to preserve patient access and outcomes while decreasing potential COVID-19 exposure to patients and healthcare providers. This model also serves to reduce the use of vital PPE. It is critical that stroke providers share best practices via academic and vetted social media platforms for rapid dissemination of tools and care models during the COVID-19 crisis.

Identifiants

pubmed: 32434728
pii: S1052-3057(20)30333-5
doi: 10.1016/j.jstrokecerebrovasdis.2020.104927
pmc: PMC7205687
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104927

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Air Med J. 2020 Mar - Apr;39(2):103-106
pubmed: 32197685
Stroke. 2020 May;51(5):1356-1357
pubmed: 32228369
N Engl J Med. 2018 Apr 26;378(17):1573-1582
pubmed: 29694815
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
J Stroke. 2013 May;15(2):78-89
pubmed: 24324943
N Engl J Med. 1995 Dec 14;333(24):1581-7
pubmed: 7477192
Stroke. 2006 Dec;37(12):2935-9
pubmed: 17095736
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131

Auteurs

Dawn Meyer (D)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States. Electronic address: dmmeyer@health.ucsd.edu.

Brett C Meyer (BC)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Karen S Rapp (KS)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Royya Modir (R)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Kunal Agrawal (K)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Lovella Hailey (L)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Melissa Mortin (M)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Richard Lane (R)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Tamra Ranasinghe (T)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Brian Sorace (B)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Tara D von Kleist (TD)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Emily Perrinez (E)

Department of Quality and Patient Safety, University of California San Diego Health, San Diego, CA 619-543-1982 United States.

Mohammed Nabulsi (M)

Department of Quality and Patient Safety, University of California San Diego Health, San Diego, CA 619-543-1982 United States.

Thomas Hemmen (T)

Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego, CA 619-543-7760, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH